Stuart Snyder

Array ( [id] => 10481945 [patent_doc_number] => 20150366961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-24 [patent_title] => 'ANTIBODY EVOLUTION IMMUNOGENS' [patent_app_type] => utility [patent_app_number] => 14/427581 [patent_app_country] => US [patent_app_date] => 2013-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 346 [patent_figures_cnt] => 346 [patent_no_of_words] => 22501 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14427581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10356423 [patent_doc_number] => 20150241428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-27 [patent_title] => 'POINT-OF-CARE ASSAY FOR THE DETECTION OF ENTEROVIRUSES USING LATERAL FLOW IMMUNOCHROMATOGRAPHIC TECHNOLOGY' [patent_app_type] => utility [patent_app_number] => 14/427880 [patent_app_country] => US [patent_app_date] => 2013-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7492 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14427880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10346223 [patent_doc_number] => 20150231228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-20 [patent_title] => 'HIV IMMUNE STIMULATING COMPOSITIONS COMPRISING RECOMBINANTLY EXPRESSED PILI ON BACTERIA AND METHODS RELATED THERETO' [patent_app_type] => utility [patent_app_number] => 14/422490 [patent_app_country] => US [patent_app_date] => 2013-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11829 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14422490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9568670 [patent_doc_number] => 20140186383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-03 [patent_title] => 'NOVEL SIMIAN T-CELL LYMPHOTROPIC VIRUS' [patent_app_type] => utility [patent_app_number] => 14/013947 [patent_app_country] => US [patent_app_date] => 2013-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 37369 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14013947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11641037 [patent_doc_number] => 09662385 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-30 [patent_title] => 'Adjuvant compositions' [patent_app_type] => utility [patent_app_number] => 14/013299 [patent_app_country] => US [patent_app_date] => 2013-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 32718 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14013299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10374423 [patent_doc_number] => 20150259429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-17 [patent_title] => 'CLUSTER OF DIFFERENTIATION 36 (CD36) AS A THERAPEUTIC TARGET FOR HIV INFECTION' [patent_app_type] => utility [patent_app_number] => 14/424456 [patent_app_country] => US [patent_app_date] => 2013-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 25000 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14424456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9477138 [patent_doc_number] => 20140134601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-15 [patent_title] => 'USE OF PROTEIN NANOPARTICLE BASED HYDROGEL' [patent_app_type] => utility [patent_app_number] => 13/938575 [patent_app_country] => US [patent_app_date] => 2013-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8942 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13938575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9294020 [patent_doc_number] => 20140037654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'THERAPEUTIC METHOD AND MEDICAMENT FOR HTLV-1 ASSOCIATED MYELOPATHY (HAM)' [patent_app_type] => utility [patent_app_number] => 13/936290 [patent_app_country] => US [patent_app_date] => 2013-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13981 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13936290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12106463 [patent_doc_number] => 09862933 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-09 [patent_title] => 'Method for in-vitro preparation of double-layered virus-like particles of rotavirus' [patent_app_type] => utility [patent_app_number] => 14/429586 [patent_app_country] => US [patent_app_date] => 2013-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 27 [patent_no_of_words] => 10556 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14429586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9222459 [patent_doc_number] => 20140017234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => 'ANTIBODIES TARGETING HIV ESCAPE MUTANTS' [patent_app_type] => utility [patent_app_number] => 13/924469 [patent_app_country] => US [patent_app_date] => 2013-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 11954 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13924469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9280728 [patent_doc_number] => 20140030697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-30 [patent_title] => 'SORTASE-MEDIATED MODIFICATION OF VIRAL SURFACE PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/918278 [patent_app_country] => US [patent_app_date] => 2013-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 41419 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13918278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11699965 [patent_doc_number] => 09689873 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-27 [patent_title] => 'Method for diagnosing and differentiating HIV-2 infections' [patent_app_type] => utility [patent_app_number] => 14/403618 [patent_app_country] => US [patent_app_date] => 2013-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 9417 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 238 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14403618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11790100 [patent_doc_number] => 09399672 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-26 [patent_title] => 'Hepatitis C virus neutralizing antibody' [patent_app_type] => utility [patent_app_number] => 14/401648 [patent_app_country] => US [patent_app_date] => 2013-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 15784 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14401648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10248534 [patent_doc_number] => 20150133530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-14 [patent_title] => 'HIGH-TRANSDUCTION-EFFICIENCY RAAV VECTORS, COMPOSITIONS, AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 14/401442 [patent_app_country] => US [patent_app_date] => 2013-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 24406 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14401442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11332443 [patent_doc_number] => 09523685 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-20 [patent_title] => 'Multiplex method for detecting an infection' [patent_app_type] => utility [patent_app_number] => 13/892521 [patent_app_country] => US [patent_app_date] => 2013-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12094 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13892521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11515533 [patent_doc_number] => 20170082607 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2017-03-23 [patent_title] => 'MALARIA ANTIGEN SCREENING METHOD' [patent_app_type] => utility [patent_app_number] => 13/866116 [patent_app_country] => US [patent_app_date] => 2013-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16490 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13866116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11515533 [patent_doc_number] => 20170082607 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2017-03-23 [patent_title] => 'MALARIA ANTIGEN SCREENING METHOD' [patent_app_type] => utility [patent_app_number] => 13/866116 [patent_app_country] => US [patent_app_date] => 2013-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16490 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13866116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9162166 [patent_doc_number] => 20130310443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-21 [patent_title] => 'AAV VECTORS WITH HIGH TRANSDUCTION EFFICIENCY AND USES THEREOF FOR GENE THERAPY' [patent_app_type] => utility [patent_app_number] => 13/840224 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 20948 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13840224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11815184 [patent_doc_number] => 09719127 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-01 [patent_title] => 'Dual inducible vectors and cell lines' [patent_app_type] => utility [patent_app_number] => 14/385824 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 84 [patent_no_of_words] => 17734 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14385824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10275243 [patent_doc_number] => 20150160240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-11 [patent_title] => 'Host Biomarkers for Dengue Fever (DF) and Methods Thereof' [patent_app_type] => utility [patent_app_number] => 14/387974 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10995 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14387974 [rel_patent_id] =>[rel_patent_doc_number] =>)